Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Bendamustine Hydrochloride MeSH Descriptor Data 2025


MeSH Heading
Bendamustine Hydrochloride
Tree Number(s)
D02.241.081.114.625
D02.455.526.728.650.103
D03.633.100.103.123
Unique ID
D000069461
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069461
Scope Note
A nitrogen mustard compound that functions as an ALKYLATING ANTINEOPLASTIC AGENT and is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA and NON-HODGKIN'S LYMPHOMA.
Entry Term(s)
Bendamustin
Bendamustine
Cytostasan
IMET 3393
Ribomustin
Treanda
Zimet 3393
Pharm Action
Antineoplastic Agents, Alkylating
Registry Numbers
981Y8SX18M
0
9266D9P3PQ
Related Numbers
16506-27-7
3543-75-7
9266D9P3PQ
Public MeSH Note
2016; BENDAMUSTINE HYDROCHLORIDE was indexed under NITROGEN MUSTARD COMPOUNDS 1982-2015 and under BENZIMIDAZOLES 1972-1982
History Note
2016 (1972)
Date Established
2016/01/01
Date of Entry
2015/07/09
Revision Date
2016/05/27
Bendamustine Hydrochloride Preferred
Zimet 3393 Narrower
Bendamustine Broader
IMET 3393 Narrower
Ribomustin Narrower
Treanda Narrower
Cytostasan Narrower
page delivered in 0.155s